Stock AnalizXometry, Inc. XMTR
Business Services · IPO 2021 · data as of November 13, 2026
Xometry, Inc. (XMTR) is a consumer discretionary company listed in the US with a market value of about $6.9B. In the twelve months to September 30, 2026 it had revenue of $879M and net income of -$17M, a net margin of -2.0%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 37% a year, a 5-year average ROIC of -9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 92% below the current price.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $879M | $687M | $546M | $463M | $381M | $218M | $141M | $80M |
| Net income | -$17M | -$62M | -$50M | -$67M | -$79M | -$61M | -$31M | -$31M |
| Free cash flow | -$19M | -$24M | -$33M | -$48M | -$76M | -$75M | -$26M | -$30M |
| EPS (diluted) | $-0.32 | $-1.07 | $-1.03 | $-1.41 | $-1.68 | $-2.33 | $-5.32 | $-4.88 |
| Net margin | -2.0% | -9.0% | -9.2% | -14.6% | -20.8% | -28.1% | -22.0% | -38.6% |
| ROIC | — | -5.8% | -9.2% | -11.6% | -9.0% | -10.4% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 11 analysts is $124.64, 4% above the current price; targets range from $107.00 to $140.00; the consensus rating is “Buy”; expected EPS is $0.83 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Xometry stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 92% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Xometry pay a dividend?
Not currently.
Is Xometry a good stock to buy?
We do not give buy or sell advice. Xometry scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.